Intralesional interferon alfa-2b as neoadjuvant treatment for perianal extramammary Paget's disease [18]

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 4, 2008, Pages 522-523

  Panasiti, V ^a   Bottoni, U ^b   Devirgiliis, V ^a   Mancini, M ^a   Rossi, M ^a   Curzio, M ^a   Calvieri, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ADJUVANT THERAPY; AGED; ANUS; CASE REPORT; CHILL; CLINICAL EXAMINATION; DISEASE DURATION; DRUG FEVER; ERYTHEMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; INJECTION PAIN; LETTER; MALE; PAGET SKIN DISEASE; PATIENT REFERRAL; PRIORITY JOURNAL; REMISSION; SEROLOGY; SKIN SURGERY;

AGED; ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; HUMANS; INJECTIONS, INTRALESIONAL; INTERFERON ALFA-2B; MALE; NEOADJUVANT THERAPY; PAGET'S DISEASE, EXTRAMAMMARY;

EID: 41149132288     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02392.x     Document Type: Letter

References (10)

1. Park S, Grossfeld GD, Mcaninch WJ, Santucci R. Extramammary Paget's disease of the penis and scrotum: Excision, reconstrusction and evaluation of occult malignancy. J Urol 2001; 166: 2112-2117.
2. Goldblum JR, Hart WR. Perianal Paget's disease: A histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma. Am J Surg Pathol 1998; 22: 170-179.
3. Raspagliesi F, Fontanelli R, Rossi G et al. Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: A pilot study. Gynecol Oncol 2006; 103: 581-586.
4. Voigt H, Bassermann R, Nathrath W. Cytoreductive combination chemotherapy for regionally advanced unresectable extramammary Paget carcinoma. Cancer 1992; 70: 704-708.
5. Tjalma WA, Cooremans ID, Jeuris W, Van Marck EA, Monaghan JM. Recurrent Paget's disease of the vulva in a myocutaneous flap: Case report and review of the literature. Eur J Gynaecol Oncol 2001; 22: 13-15.
6. Pfeffer LM, Dinarello CA, Heberman RB et al. Biological properties of recombinant a-interferons: 40th anniversary of the discovery of interferons. Cancer Res 1998; 58: 2489-2499.
7. 1 arrest in the inhibition of tumor cell growth by interferon. Proc Natl Acad Sci U S A 1980; 77: 1471-1475.
8. Borden EC. Interferons: Rationale for clinical trials in neoplastic disease. Ann Intern Med 1979; 91: 472-479.
9. Gresser I. On the mechanism of the antitumor effects of interferon. Tex Rep Biol Med 1977; 35: 394-398.
10. Yamamura M, Modlin RL, Ohmen JD, Moy RL. Local expression of antiinflammatory cytokines in cancer. J Clin Invest 1993; 91: 1005-1010.